SOPH (SOPHiA GENETICS S.A.) Stock Financials & Earnings | Market Cap Arena

SOPH (SOPHiA GENETICS S.A.) Stock Financials & Earnings | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

Mkt Cap$308M

Healthcare·Medical - Healthcare Information Services·🇨🇭 Switzerland·NASDAQ

Revenue (TTM)$77M

Net Income (TTM)-$79M

EPS (TTM)-$1.17

Free Cash Flow (TTM)-$41M

Gross Margin67.4%

Op. Margin-91.2%

Net Margin-102.2%

FCF Margin-52.6%

P/S Ratio (TTM)4.0x

P/E Ratio (TTM)—

YoY Rev Growth+18.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$14M	$10M	-$19M
Q2 23	$15M	$10M	-$20M
Q3 23	$16M	$11M	-$17M
Q4 23	$17M	$12M	-$19M
Q1 24	$16M	$10M	-$19M
Q2 24	$16M	$11M	-$15M
Q3 24	$16M	$11M	-$15M
Q4 24	$18M	$12M	-$17M
Q1 25	$18M	$12M	-$16M
Q2 25	$18M	$12M	-$19M
Q3 25	$19M	$13M	-$18M
Q4 25	$22M	$15M	-$18M

Valuation

Quarter	P/S	P/E
Q1 23	6.1x	—
Q2 23	5.7x	—
Q3 23	5.2x	—
Q4 23	4.9x	—
Q1 24	4.8x	—
Q2 24	4.7x	—
Q3 24	4.8x	—
Q4 24	4.7x	—
Q1 25	4.6x	—
Q2 25	4.4x	—
Q3 25	4.2x	—
Q4 25	4.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$15M	-$17M
Q2 23	-$10M	-$13M
Q3 23	-$12M	-$14M
Q4 23	-$11M	-$14M
Q1 24	-$15M	-$17M
Q2 24	-$10M	-$12M
Q3 24	-$7M	-$9M
Q4 24	-$11M	-$13M
Q1 25	-$11M	-$12M
Q2 25	-$8M	-$10M
Q3 25	-$9M	-$9M
Q4 25	-$9M	-$9M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$2M
Q2 23	$3M
Q3 23	$2M
Q4 23	$2M
Q1 24	$2M
Q2 24	$2M
Q3 24	$2M
Q4 24	$2M
Q1 25	$1M
Q2 25	$2M
Q3 25	$106K
Q4 25	$348K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+28.6%	-7.3%
Q2 23	+29.0%	-1.8%
Q3 23	+40.0%	-6.9%
Q4 23	+27.4%	+26.4%
Q1 24	+13.0%	+3.9%
Q2 24	+5.0%	-12.2%
Q3 24	-2.8%	-5.0%
Q4 24	+4.0%	-2.3%
Q1 25	+12.7%	-2.1%
Q2 25	+15.9%	+19.7%
Q3 25	+22.8%	+19.6%
Q4 25	+22.4%	+13.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$2M	17.4%
Q2 23	$5M	31.1%
Q3 23	$4M	24.1%
Q4 23	$4M	24.7%
Q1 24	$4M	23.5%
Q2 24	$4M	25.8%
Q3 24	$4M	22.8%
Q4 24	$5M	28.6%
Q1 25	$4M	21.6%
Q2 25	$4M	23.8%
Q3 25	$4M	21.3%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$9M	$13M	$6M	—
Q2 23	$9M	$14M	$7M	—
Q3 23	$9M	$13M	$7M	—
Q4 23	$10M	$13M	$8M	—
Q1 24	$9M	$13M	$7M	—
Q2 24	$8M	$11M	$7M	—
Q3 24	$8M	$11M	$7M	—
Q4 24	$9M	$13M	$8M	—
Q1 25	$9M	$12M	$8M	—
Q2 25	$8M	$12M	$10M	—
Q3 25	$9M	$14M	$9M	—
Q4 25	$9M	—	—	$24M

Revenue by Geography

Quarter	Asia Pacific	Europe, The Middle East And Africa	Latin America	North America
Q2 23	$846K	$11M	$937K	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$161M	$1M	$162M
Q2 23	$149M	$0	$149M
Q3 23	$133M	$0	$133M
Q4 23	$123M	$0	$123M
Q1 24	$104M	$0	$104M
Q2 24	$105M	$0	$105M
Q3 24	$96M	$0	$96M
Q4 24	$80M	$0	$80M
Q1 25	$69M	$0	$69M
Q2 25	$95M	$0	$95M
Q3 25	$82M	$0	$82M
Q4 25	$70M	$0	$70M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	64M	+0.0%
Q2 23	64M	+0.4%
Q3 23	65M	+0.9%
Q4 23	65M	-0.1%
Q1 24	65M	+0.4%
Q2 24	66M	+0.9%
Q3 24	66M	+0.7%
Q4 24	66M	-0.7%
Q1 25	67M	+1.4%
Q2 25	67M	+0.7%
Q3 25	68M	+0.7%
Q4 25	68M	+0.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	$78K	518
FY 22	$102K	466
FY 23	$139K	449
FY 24	$679K	96
FY 25	$729K	106